BioVersys
Phase 3Antibiotic-resistant germs are among the most important medical threats of our day and age. ▷ Find out more about our mission to tackle this challenge!
Founded
2008
Focus
Small Molecules
About
Antibiotic-resistant germs are among the most important medical threats of our day and age. ▷ Find out more about our mission to tackle this challenge!
Funding History
7Total raised: $105M
Grant$5MCARB-XMar 15, 2022
Series C$25MBB Biotech VenturesJan 15, 2022
Series C$20MUndisclosedDec 15, 2020
Series B$20MBB Biotech VenturesFeb 15, 2019
Company Info
TypePrivate
Founded2008
LocationBasel, Switzerland
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile